Observation:
During the 12 week trial, the mean values in group NC for body weight and fat content significantly decreased, whereas lean body mass and total body water significantly increased compared to the baseline values and C group values.
Percentage of subjects who experienced weight loss
Percentage of weight loss at consecutive study time intervals
top
Percentage BMI Change at two study time intervals
top
Percentage change in Lean Body Mass (LBM) in C Group (Citrin®) subjects
top
Percentage change in Lean Body Mass (LBM) in NC Group (GarCitrin®) subjects
The appetite levels were significantly less in the NC group than the C group, whereas energy levels were equally increased in both study groups as compared to the baseline.
Self assessed appetite levels in the two groups at consecutive study time intervals
No subjective or objective adverse effects were reported in the course of this study. The pulse rate, systolic and diastolic blood pressure were maintained at the same level throughout the study.
In this human double blind clinical trial on GarCitrin®, it was found to be statistically more effective than HCA in:
reducing total body weight and body mass index reducing body fat increasing lean body mass and content of body water reducing levels of appetite perception
Also both GarCitrin® and HCA did not produce subjective or objective side effects.
top
|
